Cargando…

Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B

More than 20 years after the identification of the hepatitis C virus (HCV) as a novel human pathogen, the only approved treatment remains a combination of pegylated interferon-α and ribavirin. This rather non-specific therapy is associated with severe side effects and by far not everyone benefits fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Powdrill, Megan H., Bernatchez, Jean A., Götte, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185568/
https://www.ncbi.nlm.nih.gov/pubmed/21994615
http://dx.doi.org/10.3390/v2102169